GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

Specialty pharmaceutical firm for rare diseases and unmet medical needs.

GENIL | IS

Overview

Corporate Details

ISIN(s):
TREGENL00016 (+1 more)
LEI:
789000A4NW6W4D8Z4H25
Country:
Türkiye
Address:
MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA

Description

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. is a specialty pharmaceutical company established in 1998 that provides solutions for rare diseases and unmet medical needs. The company operates a GMP-certified manufacturing facility and an R&D center to develop, produce, and supply a wide range of products for international markets. Its business model combines strategic partnerships with global firms and in-house innovation to address complex health challenges, leveraging over 25 years of experience in its specialized therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 16:04
Participation in Subsidiary Capital Increase
Turkish 19.8 KB
2025-11-12 11:44
Company General Info Form
Turkish 3.8 KB
2025-11-11 12:55
Appointment of Investor Relations Manager
Turkish 18.1 KB
2025-11-10 13:58
Kar Payının 3. Taksitinin Ödenmesi
Turkish 358.5 KB
2025-11-10 13:58
Kar Payının 3. Taksitinin Ödenmesi
English 38.6 KB
2025-11-10 06:03
01.01.2025 - 30.09.2025 Sorumluluk Beyanı
Turkish 19.9 KB
2025-11-10 06:03
01.01.2025 - 30.09.2025 Interim Period Activity Report
English 1.1 MB
2025-11-10 06:03
01.01.2025 - 30.09.2025 Interim Period Activity Report
Turkish 2.0 MB
2025-11-10 06:03
01.01.2025 - 30.09.2025 Interim Period Activity Report
English 11.5 KB
2025-11-10 06:03
Financial Report
Turkish 2.6 MB
2025-11-10 06:03
Financial Report
English 2.6 MB
2025-10-21 18:22
Company General Info Form
English 12.4 KB
2025-09-30 17:10
Company General Info Form
English 2.8 KB
2025-09-30 17:10
Investor Relations Manager Resignation
Turkish 18.4 KB
2025-09-30 17:10
Turkish Sustainability Reporting Standards Compliant Sustainability Report
Turkish 15.9 KB

Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.